4 Results for "

human leukaemia CCRF-CEM cells

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "human leukaemia CCRF-CEM cells" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-N1365
CAS No.: 776-86-3
Synonyms: 6-Hydroxy-7-methoxycoumarin
Isoscopoletin (6-Hydroxy-7-methoxycoumarin) is an active constituent in Artemisia argyi leaves. Isoscopoletin shows substantial inhibition against cell proliferation, with IC50s of 4.0 μM and 1.6 μM for human CCRF-CEM leukaemia cells and multidrug resistant subline CEM/ADR5000, respectively . Isoscopoletin (6-Hydroxy-7-methoxycoumarin) possesses inhibitory activity against HBV replication . Isoscopoletin exhibits anti-inflammatory activity through inhibition of MAPK/NF-κB/STAT/AKT signaling pathway .
loading...
    loading...
Cat. No.: HY-100777
CAS No.: 89459-25-6
Purity:  ≥98.0%
Target:  

Topoisomerase

Research Areas:  

Neurological Disease Cancer

DACA (XR 5000) is a potential and blood-brain barrier-penetrating topoisomerase I and II inhibitor. DACA can be used in the research of colorectal cancer, leukemia and lung cancer .
loading...
    loading...
Cat. No.: HY-N1365R
CAS No.: 776-86-3
Synonyms: 6-Hydroxy-7-methoxycoumarin (Standard)
Isoscopoletin (Standard) is the analytical standard of Isoscopoletin. This product is intended for research and analytical applications. Isoscopoletin (6-Hydroxy-7-methoxycoumarin) is an active constituent in Artemisia argyi leaves. Isoscopoletin shows substantial inhibition against cell proliferation, with IC50s of 4.0 μM and 1.6 μM for human CCRF-CEM leukaemia cells and multidrug resistant subline CEM/ADR5000, respectively . Isoscopoletin (6-Hydroxy-7-methoxycoumarin) possesses inhibitory activity against HBV replication . Isoscopoletin exhibits anti-inflammatory activity through inhibition of MAPK/NF-κB/STAT/AKT signaling pathway .
loading...
    loading...
Cat. No.: HY-100777R
CAS No.: 89459-25-6
Research Areas:  

Cancer

DACA (Standard) is the analytical standard of DACA (HY-100777). This product is intended for research and analytical applications. DACA (XR 5000) is a blood-brain barrier-penetrating topoisomerase I and II inhibitor. DACA can be used in the research of colorectal cancer, leukemia and lung cancer .
loading...
    loading...